[Combination assay of tumor markers in predicting the effectiveness of chemotherapy in non-small lung cancer].
Satoh
H
H
Department of Respiratory Internal Medicine, Tsukuba University, Japan.
Yano
H
H
Suyama
T
T
Hasegawa
S
S
D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016256:Lewis X Antigen / Q000032:analysis; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015843:Serpins
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D016256:Lewis X Antigen; D015843:Serpins; C051072:squamous cell carcinoma-related antigen